Actively Recruiting
Feasibility Study on Implementing Consultation-based High-quality Palliative Care Services in Intensive Care Units
Led by Seoul National University Hospital · Updated on 2024-07-08
20
Participants Needed
1
Research Sites
80 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Critically ill patients in intensive care units (ICUs) receive life-sustaining treatments aimed at restoring or maintaining organ function. ICU admission often involves substantial physical and existential pressures that can burden patients, their families, and surrogates. Multidisciplinary palliative care support can help alleviate potential causes of suffering. Twenty patients admitted to the ICUs at Seoul National University Hospital, diagnosed with sudden and severe acute brain injury or progressive organ failure, along with their surrogates, will be enrolled in the study. This study aims to assess the feasibility of applying consultation-based palliative care services to provide higher quality palliative care for critically ill patients with acute illnesses and their families facing poor prognoses upon ICU admission. Additionally, the study seeks to determine whether providing such palliative care services can help better respect the patient's values and goals, reduce communication conflicts, alleviate family caregivers' anxiety and depression, and enhance satisfaction with critical care.
CONDITIONS
Official Title
Feasibility Study on Implementing Consultation-based High-quality Palliative Care Services in Intensive Care Units
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with sudden and severe acute brain injury due to vascular, traumatic, metabolic, toxic, infectious, or anoxic causes
- Glasgow Coma Scale score of 3-8 for at least 24 hours after admission
- Patients unable to express themselves verbally or otherwise
- OR patients diagnosed with advanced stage organ failure including chronic lung disease requiring oxygen or ventilation, decompensated liver cirrhosis, chronic heart failure NYHA class III or IV, progressive neurological disease with modified Rankin score 3-5, or three or more chronic comorbidities limiting daily activities
- APACHE II score of 14 or higher at screening
- ICU stay of 7 days or more
- Surrogates who are family caregivers of eligible patients
- Surrogates aged 19 or older
- Surrogates willing and able to provide consent
You will not qualify if you...
- Patients under 19 years of age
- Patients unable to speak, understand, or read Korean
- Patients who refuse palliative care consultation
- Patients referred to palliative care before enrollment
- Patients within 48 hours of ICU admission
- Patients with active cancer under treatment within 6 months before ICU admission
- Patients with care goals set to "comfort care" at enrollment
- Patients expected to die within 48 hours at enrollment
- Patients lacking capacity to participate without a surrogate
- Surrogates under 19 years of age
- Surrogates unable to speak, understand, or read Korean
- Surrogates in extremely poor health making participation infeasible
- Surrogates who refuse palliative care consultation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, N/A (Not Applicable), South Korea, 03080
Actively Recruiting
Research Team
S
Shin Hye Yoo
CONTACT
Y
Ye Sul Jeung
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here